Limited data are available regarding the use of nab-paclitaxel in older patients with breast cancer. A weekly schedule is recommended, but there is a paucity of evidence regarding the optimal dose. We evaluated the efficacy of two different doses of weekly nab-paclitaxel, with a specific focus on their corresponding impact on patient function, in order to address the lack of data specifically relating to the older population.

EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer / Biganzoli, Laura; Cinieri, Saverio; Berardi, Rossana; Pedersini, Rebecca; Mccartney, Amelia; Minisini, Alessandro Marco; Caremoli, Elena Rota; Spazzapan, Simon; Magnolfi, Emanuela; Brunello, Antonella; Risi, Emanuela; Palumbo, Raffaella; Leo, Silvana; Colleoni, Marco; Donati, Sara; De Placido, Sabino; Orlando, Laura; Pistelli, Mirco; Parolin, Veronica; Mislang, Anna; Becheri, Dimitri; Puglisi, Fabio; Sanna, Giuseppina; Zafarana, Elena; Boni, Luca; Mottino, Giuseppe. - In: BREAST CANCER RESEARCH. - ISSN 1465-542X. - 22:1(2020), p. 83. [10.1186/s13058-020-01319-1]

EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer

De Placido, Sabino;Orlando, Laura;
2020

Abstract

Limited data are available regarding the use of nab-paclitaxel in older patients with breast cancer. A weekly schedule is recommended, but there is a paucity of evidence regarding the optimal dose. We evaluated the efficacy of two different doses of weekly nab-paclitaxel, with a specific focus on their corresponding impact on patient function, in order to address the lack of data specifically relating to the older population.
2020
EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer / Biganzoli, Laura; Cinieri, Saverio; Berardi, Rossana; Pedersini, Rebecca; Mccartney, Amelia; Minisini, Alessandro Marco; Caremoli, Elena Rota; Spazzapan, Simon; Magnolfi, Emanuela; Brunello, Antonella; Risi, Emanuela; Palumbo, Raffaella; Leo, Silvana; Colleoni, Marco; Donati, Sara; De Placido, Sabino; Orlando, Laura; Pistelli, Mirco; Parolin, Veronica; Mislang, Anna; Becheri, Dimitri; Puglisi, Fabio; Sanna, Giuseppina; Zafarana, Elena; Boni, Luca; Mottino, Giuseppe. - In: BREAST CANCER RESEARCH. - ISSN 1465-542X. - 22:1(2020), p. 83. [10.1186/s13058-020-01319-1]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/890586
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 5
social impact